Biomarkers for Colorectal Cancer
Open Access
- 12 September 2010
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 11 (9), 3209-3225
- https://doi.org/10.3390/ijms11093209
Abstract
Colorectal cancer (CRC) is the third most common epithelial malignancy in the world. Since CRC develops slowly from removable precancerous lesions, detection of the lesion at an early stage by regular health examinations can reduce the incidence and mortality of this malignancy. Colonoscopy significantly improves the detection rate of CRC, but the examination is expensive and inconvenient. Therefore, we need novel biomarkers that are non-invasive to enable us to detect CRC quite early. A number of validation studies have been conducted to evaluate genetic, epigenetic or protein markers for identification in the stool and/or serum. Currently, the fecal occult blood test is the most widely used method of screening for CRC. However, advances in genomics and proteomics will lead to the discovery of novel non-invasive biomarkers.Keywords
This publication has 93 references indexed in Scilit:
- Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent AdvancementsSeminars in Liver Disease, 2010
- Alzheimer’s disease biomarker discovery in symptomatic and asymptomatic patients: Experimental approaches and future clinical applicationsExperimental Gerontology, 2010
- MicroRNAs in Barrett's esophagus and esophageal adenocarcinomaCurrent Opinion in Pharmacology, 2009
- New tools for functional genomic analysisDrug Discovery Today, 2009
- MicroRNA involvement in glioblastoma pathogenesisBiochemical and Biophysical Research Communications, 2009
- Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patientsBritish Journal of Cancer, 2007
- Increased Serum Levels of Complement C3a Anaphylatoxin Indicate the Presence of Colorectal TumorsGastroenterology, 2006
- Diet and cancer — the European Prospective Investigation into Cancer and NutritionNature Reviews Cancer, 2004
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996